Catalyst Wire Dossier Catalyst Wire Dossier

CKD-519 New Formulation

CKD-519 · Chong Kun Dang Pharmaceutical
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-519 New Formulation, covering 2016-01-20 to 2016-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. [Phase 1]

See pricing